GP-100 antigen Completed Phase 2 Trials for Recurrent Intraocular Melanoma / Extraocular Extension Melanoma Treatment

Indications	Status	Purpose	Phase
DBCOND0029488 (Recurrent Intraocular Melanoma) DBCOND0029487 (Extraocular Extension Melanoma)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00020475	Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye	GP-100 antigen (DB14800) Human interleukin-2 (DB14865) Incomplete Freund's adjuvant (DB17475)